Kilitch Drugs announces rights issue for equity shares

Kilitch Drugs (India) Ltd. has announced a rights issue of its equity shares, having received in-principle approval from both the BSE Limited and the National Stock Exchange of India. The Board of Directors approved the terms of the rights issue at a meeting held on July 9, 2025. The company plans to issue 1,398,463 fully paid-up equity shares with a face value of INR 10 each, offered at an issue price of INR 357 per share, payable upon application. The record date for determining eligible equity shareholders for the rights issue is set for July 15, 2025. Shareholders will be entitled to two rights equity shares for every 23 equity shares held on the record date, with the option to renounce their rights. Prior to the rights issue, the company has 1,6082,319 equity shares outstanding and that is expected to increase to 1,7480,782 after the issue, assuming full subscription.